Back to Aurora® or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Terpene Profile (Comparative Values)

Alpha-Pinene21.31% Pine/Sharp156℃
Beta-Pinene21.31% Pine/Herbal165℃
Myrcene27.87% Herbal/Musk166-168℃
Terpinolene29.5% Floral/Herbal185℃

MedBud currently tracks 16 common terpenes, more will be added.

Dosing Look-Up Table (Estimated)

0.01/g2.2/mg THC0.1/mg CBD
0.05/g11/mg THC0.5/mg CBD
0.1/g22/mg THC1/mg CBD
0.15/g33/mg THC1.5/mg CBD
0.2/g44/mg THC2/mg CBD
0.25/g55/mg THC2.5/mg CBD
0.3/g66/mg THC3/mg CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
Canada Aurora®
Designation
T22
Cultivar/Strain
Delahaze
Classification
Sativa Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
19.8-24.2%
CBD Potential Range (±10%)
1%
Cultivated/Produced by
Flag of Canada Aurora Canada
Cultivated in
Flag of Canada Canada
Irradiation
Beta-Irradiated
Monograph Conformity
5.1.4
Imported by
United Kingdom IPS Pharma
Imported as
Schedule II: Finished Product
Packaged in
Flag of Canada Canada

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Awaiting ETA

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Product Description Video Reviews3 Patient Reviews

About Delahaze

DLHSativa Hybrid

Paradise Strains experimented with crossbreeding their Mango Haze and Lemon Skunk plants. The bud is a perfect combination of its parent flowers: pungent and skunky with hints of fruit, citrus, and earth mixed in.

Dutch Flag Dutch Bred

Delahaze is a hybrid strain that leans toward Sativa dominance. This strain was developed by the brilliant and classic growers at Paradise Seeds in Amsterdam. Paradise Strains experimented with crossbreeding their Mango Haze and Lemon Skunk plants until eventually Delahaze was born.

The flavor profile is one of Delahaze’s strongest selling points. Many users report that out of the packaging, the bud is a perfect combination of its parent flowers: pungent and skunky with hints of fruit, citrus, and earth mixed in. This scent expands when ground up and burned, as the smoke tastes of ripe mango, sweet-and-sour citrus, and dirt. Although these elements seem like they wouldn’t go together, they combine into an incredibly smooth and enjoyable hit from any form of consumption. Like most Sativas, Delahaze nugs are elongated and spearlike in shape. They are typically dark or forest green in color, with a thick coating of orange pistils and tiny white trichomes.

Upon exhaling the smooth, peppery smoke of Delahaze, users are greeted with a rush of cerebral energy. As you drum up nothing but happy thoughts, you quickly realize your pain has melted away into nothing and you can finally relax. Not long after your sesh is over, you’ll be able to clearly focus on the tasks in front of you, without worry of physical pain stopping you. Delahaze’s high is an energetic and creative high, users often find themselves tackling large projects they had been procrastinating on. This makes Delahaze the perfect strains for wake-and-bakes or taking a quick walk with the dog.

Description provided by Wikileaf.

Information provided could come from a third-party source, and likely does not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).

Canada About Aurora Europe GmbH

Aurora® Logo

Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond.

Aurora Cannabis is a leading integrated cannabis company with a robust network of subsidiaries and strategic partnerships. With state-of-the-art production facilities and exclusive sales agreements in the European Union and beyond, Aurora operates around the globe pursuing new and emerging cannabis markets. Through the Company’s unparalleled pace of execution and commitment to innovation, Aurora has become one of the world’s largest and fastest growing cannabis companies that continues to elevate and challenge industry standards.

Aurora has three operational facilities in Canada (Aurora Sky, Aurora Vie, and Aurora Mountain) plus two new facilities projected to be operational by the end of 2019, including a 1,000,000-square-foot (93,000 m2) facility under construction in Odense, Denmark. Construction on the Nordic 2 project in Denmark was stopped in November 2019 when the company's stock dropped to a two year low. The Aurora Sun project in Alberta was put on a temporary hold. These decisions would lead to a savings of $190 million.

Aurora Mountain was Aurora's first facility, completed in 2015. It is a 55,200-square-foot (5,130 m2) production facility in Mountain View County. Aurora Vie is a 40,000-square-foot (3,700 m2), fully licensed, indoor production facility in Pointe-Claire, Quebec. It was the second licensed producer in Quebec, and was acquired in 2017 for $7 million when it was about 80% complete. In 2017, Aurora Cannabis began construction of an automated 800,000-square-foot (74,000 m2) plant in Alberta that it said would be capable of producing 100,000 kilograms of cannabis annually. The land is part of the acreage owned by the Edmonton International Airport. In 2021, Aurora shuttered its Aurora Polaris facility in Edmonton.

auroramj.com

  Information provided is partially community sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)